COMBACTE-CARE: A New Public-Private Funded Project to Combat Carbapenem Resisitance
combacte-care
Press Release
COMBACTE-CARE
COMBACTE-CARE is laying the groundwork for tests of new and more effective treatments for when the current available antibiotics no longer suffice.
Download press release
Related trials
Want to stay up to date?
Subscribe to our newsletter!
Share this press release
Related library items
-
combacte-care Publication
Pharmacokinetics and Safety of Aztreonam/Avibactam for the Treatment of Complicated Intra-Abdominal Infections in Hospitalized Adults: Results from the REJUVENATE Study
Cornely OA, Cisneros JM, Torre-Cisneros J, Rodríguez-Hernández MJ, Tallón-Aguilar L, Calbo E, Horcajada JP, Queckenberg C, Zettelmeyer U, Arenz D, et al. Pharmacokinetics and Safety of Aztreonam/Avibactam for the Treatment of Complicated Intra-Abdominal Infections in Hospitalized Adults: Results from the REJUVENATE Study. J Antimicrob Chemother. 2019 Dec 12. pii: dkz497 -
combacte-care Publication
Profile of the SeptiCyte™ LAB Gene Expression Assay to Diagnose Infection in Critically Ill Patients
Verboom DM, Koster-Brouwer ME, Varkila MRJ, Bonten MJM, Cremer OL. Profile of the SeptiCyte™ LAB Gene Expression Assay to Diagnose Infection in Critically Ill Patients. Expert Rev Mol Diagn. 2019 Feb;19(2):95-108
